-
IntroducedMar 30, 2023
-
Passed HouseMay 11, 2023
-
Passed SenateMay 29, 2023
-
Signed into LawJun 06, 2023
INSURANCE: Authorizes substitution of certain biosimilar biological products relative to step therapy or fail first protocols
Last Action See all actions
House • Jun 06, 2023: Effective date: 08/01/2023.
Latest Bill Text See all bill texts
Summary/Bill Text
Comments on HB 403
Tweets
Whip Lists
Sponsors
Votes
YES: 92
- Mr. Speaker
- Fontenot
- McKnight
- Adams
- Freeman
- McMahen
- Amedee
- Freiberg
- Miguez
- Bacala
- Frieman
- Miller, D.
- Bagley
- Gadberry
- Miller, G.
- Beaullieu
- Gaines
- Mincey
- Bishop
- Garofalo
- Moore
- Bourriaque
- Glover
- Muscarello
- Boyd
- Goudeau
- Nelson
- Brass
- Green
- Orgeron
- Brown
- Hodges
- Owen, C.
- Bryant
- Horton
- Owen, R.
- Butler
- Hughes
- Pierre
- Carpenter
- Huval
- Pressly
- Carrier
- Illg
- Riser
- Carter, R.
- Ivey
- Romero
- Carter, W.
- Jenkins
- Schamerhorn
- Cormier
- Johnson, M.
- Schlegel
- Coussan
- Jordan
- Seabaugh
- Cox
- Kerner
- Selders
- Crews
- Knox
- St. Blanc
- Deshotel
- LaCombe
- Stagni
- DeVillier
- LaFleur
- Thomas
- DuBuisson
- Landry
- Thompson
- Echols
- Larvadain
- Turner
- Edmonds
- Lyons
- Villio
- Edmonston
- Mack
- Wheat
- Emerson
- Magee
- White
- Farnum
- Marcelle
- Willard
- Firment
- McCormick
- Zeringue
- Fisher
- McFarland
NO: 0
ABSENT: 13
Actions
- Jun 06, 2023 | House
- Signed by the Governor. Becomes Act No. 125.
- Effective date: 08/01/2023.
- Jun 01, 2023 | House
- Sent to the Governor for executive approval.
- May 31, 2023 | Senate
- Signed by the President of the Senate.
- May 31, 2023 | House
- Enrolled and signed by the Speaker of the House.
- May 30, 2023 | House
- Received from the Senate without amendments.
- May 29, 2023 | Senate
- Rules suspended. Read by title, passed by a vote of 39 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.
- May 26, 2023 | Senate
- Reported without Legislative Bureau amendments. Read by title and passed to third reading and final passage.
- May 25, 2023 | Senate
- Read by title and referred to the Legislative Bureau.
- May 24, 2023 | Senate
- Reported favorably.
- May 16, 2023 | Senate
- Read second time by title and referred to the Committee on Insurance.
- May 15, 2023 | Senate
- Received in the Senate. Read first time by title and placed on the Calendar for a second reading.
- May 11, 2023 | House
- Read third time by title, roll called on final passage, yeas 92, nays 0. Finally passed, title adopted, ordered to the Senate.
- May 04, 2023 | House
- Scheduled for floor debate on 05/11/2023.
- May 03, 2023 | House
- Read by title, ordered engrossed, passed to 3rd reading.
- May 02, 2023 | House
- Reported favorably (11-0).
- Apr 10, 2023 | House
- Read by title, under the rules, referred to the Committee on Insurance.
- Apr 03, 2023 | House
- First appeared in the Interim Calendar on 4/3/2023.
- Mar 30, 2023 | House
- Prefiled.
- Under the rules, provisionally referred to the Committee on Insurance.